AbbVie stock trades 0.90 percent above its Xetra close of EUR 244.40 in weekend trading

Published on 10/10/2026 at 10:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AbbVie stock costs EUR 246.60 in weekend trading on October 10, 2026 versus a Xetra close of EUR 244.40. Xetra remains closed.

Key points in brief

EUR 246.60 in weekend trading at Lang & Schwarz
Up 0.90 percent versus the EUR 244.40 close on October 9, 2026
AbbVie scheduled third-quarter results for October 30, 2026

Pop-Art-Comicillustration mit stilisierter DNA-Doppelhelix und Antikörper-Superhelden im Lichtenstein-Stil — AbbVie Inc. US00287Y1091 Pop Art Comic stilisierte DNA Doppelhelix Antikörper Superhelden Halbtondruck Lichtenstein Stil, Illustration mit AI erstellt.

AbbVie stock was at EUR 246.60 in weekend trading at Lang & Schwarz on October 10, 2026, at 10:14 a.m. CEST. That was plus 0.90 percent versus the EUR 244.40 close at Lang & Schwarz on October 9, 2026.

The week in figures

The weekend indication stood at EUR 246.60, compared with the EUR 244.40 close at Lang & Schwarz on October 9, 2026. The bid was EUR 246.40 and the ask was EUR 246.80.

The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of AbbVie stock.

Chronology of the week

On October 1, 2026, AbbVie announced that it will report third-quarter 2026 financial results on October 30, 2026, before the market opens. The company said its earnings call will begin at 8:00 a.m. Central time. Nasdaq published the issuer-provided announcement.

Dates of the coming week

The next Xetra session is October 12, 2026. AbbVie’s next scheduled company date identified in the fetched announcement is October 30, 2026, when it plans to announce third-quarter 2026 results before the market opens. Nasdaq carried the release from AbbVie.

Market context: Market report S&P 500.